Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06578104 · ClinicalTrials.gov registry record

PULSED AF Post-Approval Study

A clinical trial of Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.

Recruiting
Registry status
580
Enrollment target
16
Study locations

NCT06578104 is a study of Atrial Fibrillation that is actively recruiting participants, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 580 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower). The trial reports 16 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06578104, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by Medtronic Cardiac Ablation Solutions.

RECRUITING
Registry status
580 participants
Enrollment target
16
Study locations

Study Summary

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE PulseSelect™ PFA system

Study Locations (16)

Ohio

  • Bethesda North Hospital - Cincinnati
  • The Ohio State University Wexner Medical Center - Columbus
  • Mount Carmel Grove City Medical Center - Grove City

New York

  • The Valley Hospital - New York
  • Northwell Health Lenox Hill Hospital - New York

South Carolina

  • AnMed Health Center - Anderson
  • Medical University of South Carolina (MUSC) - Charleston

Florida

  • University of South Florida Health (USF) - Tampa

Kentucky

  • Pikeville Medical Center - Whitesburg

Massachusetts

  • Southcoast Health System - Fall River

Michigan

  • Beaumont Health System - Royal Oak

Nebraska

  • Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 580 participants
Start Date 2024-11-04
Est. Completion 2029-06-01

Sponsor

Medtronic Cardiac Ablation Solutions

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06578104

The ClinicalTrials.gov registry entry for NCT06578104 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower). The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which PulseSelect™ PFA system is the first listed.

NCT06578104 reports 16 study locations spanning 12 distinct geographic areas - top geographies include Ohio, New York, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06578104 about?

NCT06578104 is a clinical study titled "PULSED AF Post-Approval Study". PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

What is the current status of trial NCT06578104?

This trial is currently recruiting. The enrollment target is 580 participants. The study started on 2024-11-04. Estimated completion is 2029-06-01.

What conditions does trial NCT06578104 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT06578104?

The interventions under investigation include: PulseSelect™ PFA system (DEVICE).

Who is sponsoring clinical trial NCT06578104?

This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06578104 being conducted?

This trial has 16 study locations across Florida, Kentucky, Massachusetts, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.